We are pleased to announce that the acquisition of Avid Bioservices by GHO Capital Partners and Ampersand Capital Partners has been completed. Read the Press Release

All Resources

Mammalian Protein DS Line 2 Tour

February 2, 2025

Take a virtual tour of our DS Line 2 facility, dedicated to CGMP mammalian protein drug substance manufacturing.

All Resources

Mammalian Protein DS Line 2 Tour

Sign up for Avid emails.

Follow Us:

Get the latest from Avid.

Follow Us:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content: